Sonnet Biotherapeutics Holdings Stock Price on April 20, 2024
| SONN Stock | USD 1.51 0.02 1.34% |
Below is the normalized historical share price chart for Sonnet Biotherapeutics Holdings extending back to July 27, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sonnet Biotherapeutics stands at 1.51, as last reported on the 28th of December, with the highest price reaching 1.54 and the lowest price hitting 1.44 during the day.
If you're considering investing in Sonnet Stock, it is important to understand the factors that can impact its price. Sonnet Biotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.31, which indicates the firm had a -0.31% return per unit of risk over the last 3 months. Sonnet Biotherapeutics Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sonnet Biotherapeutics' Variance of 49.17, risk adjusted performance of (0.19), and Coefficient Of Variation of (392.72) to confirm the risk estimate we provide.
Sonnet Biotherapeutics reported last year Total Stockholder Equity of (485,739). As of the 28th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 29.8 M, while Other Stockholder Equity is likely to drop about 64.1 M. . At this time, Sonnet Biotherapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 28th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.19, while Price To Sales Ratio is likely to drop 1.18. Sonnet Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of October 2006 | 200 Day MA 8.4211 | 50 Day MA 3.2666 | Beta 1.045 |
Sonnet |
Sharpe Ratio = -0.3146
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SONN |
Estimated Market Risk
| 6.72 actual daily | 59 59% of assets are less volatile |
Expected Return
| -2.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.31 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sonnet Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sonnet Biotherapeutics by adding Sonnet Biotherapeutics to a well-diversified portfolio.
Price Book 2.0666 | Enterprise Value Ebitda (0.21) | Price Sales 81.2659 | Shares Float 586 K | Wall Street Target Price 160 |
Sonnet Biotherapeutics Main Headline on 19th of April 2024
Acquisition by Pruitt Michael D of 1000 shares of Sonnet Bio... by Pruitt Michael D
Filed transaction by Sonnet Biotherapeutics Holdings Director, Officer Ceo, Chairman. Grant, award or other acquisition pursuant to Rule 16b-3
Sonnet Biotherapeutics Valuation on April 20, 2024
It is possible to determine the worth of Sonnet Biotherapeutics on a given historical date. On April 20, 2024 Sonnet was worth 14.32 at the beginning of the trading date compared to the closed value of 14.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sonnet Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Sonnet Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sonnet Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sonnet Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.60 | 14.20 | 13.60 | 14.16 | 2,248 | |
04/19/2024 | 14.32 | 15.12 | 14.16 | 14.56 | 2,820 |
| 14.16 | 14.24 | 13.48 | 13.56 | 2,252 |
| Backtest Sonnet Biotherapeutics | | | Sonnet Biotherapeutics History | | | Sonnet Biotherapeutics Valuation | Previous | Next |
Sonnet Biotherapeutics Trading Date Momentum on April 20, 2024
| On April 22 2024 Sonnet Biotherapeutics Holdings was traded for 13.56 at the closing time. The top price for the day was 14.24 and the lowest listed price was 13.48 . The trading volume for the day was 2.3 K. The trading history from April 22, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 6.87% . The trading price change against the current closing price is 2.20% . |
Sonnet Biotherapeutics Fundamentals Correlations and Trends
By evaluating Sonnet Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sonnet Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sonnet financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sonnet Biotherapeutics Stock history
Sonnet Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sonnet is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sonnet Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sonnet Biotherapeutics stock prices may prove useful in developing a viable investing in Sonnet Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 655.2 K | 440 | |
| Net Loss | -16.1 M | -16.9 M |
Sonnet Biotherapeutics Stock Technical Analysis
Sonnet Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sonnet Biotherapeutics Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Sonnet Biotherapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sonnet Biotherapeutics December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Sonnet Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonnet Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Sonnet Biotherapeutics stock market strength indicators, traders can identify Sonnet Biotherapeutics Holdings entry and exit signals to maximize returns
Sonnet Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sonnet Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Sonnet Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sonnet to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.79) | |||
| Total Risk Alpha | (1.99) | |||
| Treynor Ratio | 7.77 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.35) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.50) | Return On Assets (0.97) | Return On Equity (2.65) |
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.